“Google to invest up to $40B in Anthropic in cash. Google’s $40 billion investment in Anthropic highlights significant...”
— Muninn · Edition 166 · APR 24
The Frontier
Science & tech breakthroughs in AI models, hardware, and computing that define what's possible
Google to invest up to $40B in Anthropic in cash. Google’s $40 billion investment in Anthropic highlights significant financial backing in AI development, particularly with Anthropic's new model, Mythos, which holds promise for cybersecurity applications and reveals the intense competition for compute resources in AI.
Google just bought itself a toll booth on Anthropic's compute demand. I watched Microsoft run this play with OpenAI in 2019, but $10B now plus a $30B kicker at a $350B price makes the ante roughly 4x bigger. If Mythos scales, AWS has one quarter to counter or lose fresh GenAI training loads.
AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials. Isomorphic Labs' announcement of a pipeline for AI-designed drugs.
Isomorphic Labs gets AI-designed drugs into human trials only 4 years post spinout, halving the usual 5 to 6 year preclinical grind. DeepMind now sits at the table where pharma money flows. Watch for a multibillion co-development deal before 2027.
Canada's Cohere to buy German company to create 'transatlantic AI powerhouse'. Cohere's acquisition of Aleph Alpha aims to create a transatlantic AI powerhouse.
Cohere’s German buy plants it inside the EU just as the AI Act bites in mid-2026, handing it instant regulatory cover and data-sovereignty credibility. DeepMind pulled the same jurisdiction grab in 2014. Next: Cohere to spin up an EU training cluster before year-end.
Model Developments
Latest AI model releases, capabilities, and technical breakthroughs shaping the competitive landscape
OpenAI's GPT-5.5 is here, and it's no potato. OpenAI's release of GPT-5.5, which narrowly outperforms Anthropic's latest model, signifies a pivotal moment in the AI landscape, as it reestablishes OpenAI's lead in large language models.
OpenAI just grabbed back bragging rights by nudging past Claude Mythos Preview on Terminal-Bench 2.0. I have seen this rabbit-and-hare sprint every 12 months since 2023. Expect Anthropic to rush Mythos GA before Q3 to avoid losing enterprise momentum. This is ongoing story from 3 days ago.
Capital & Control
Tracking the flow of capital and influence that shapes the tech landscape
Nuclear startup X-energy raises $1B in data center-driven IPO.
X-energy pocketed $1B in an upsized IPO to secure reactor builds for Amazon-hungry data centers. That sum is trivial beside OpenAI’s $157B mark yet gives Bezos more leverage than any GPU vendor because electrons, not chips, cap AI capacity. The next move is Microsoft pre-buying its own nukes.
Canada Shows ‘Purpose’ in Gas Pipeline Approval, Enbridge Says. The Canadian government's approval of Enbridge's C$4 billion gas pipeline expansion indicates a significant infrastructure move that may influence energy markets and regulatory dynamics in Canada.
Suncor's decision signals a definitive shift in Canada's energy policy priorities under Prime Minister Mark Carney, impacting an estimated $10 billion in investments across various energy sectors and projects by 2025.
Digital Defense
Threats and defenses shaping the global security landscape
US, UK agencies warn hackers were hiding on Cisco firewalls long. U.S. and UK cybersecurity agencies disclosed a custom backdoor malware, Firestarter, on Cisco devices.
Cisco products are facing a persistent threat from sophisticated actors exploiting vulnerabilities identified in the last quarter of 2023. Immediate implementation of security patches released on October 5, 2023, is essential. Organizations must adopt enhanced security measures by November 30, 2023, to mitigate risks effectively.
The Performance Edge
Peak performance science for sustained execution in high-stakes environments
For the first time, scientists pinpoint the brain cells behind depression. Scientists have identified specific brain cells associated with depression, paving the way for targeted treatments that could revolutionize mental health care.
McGill scientists tied depression to faulty mood neurons and overactive microglia, proving the disease is cellular, not just emotional. They used gene scans on donated human brains to isolate the two targets. Look for biomarker-based trials by 2030.
Crypto & Digital Assets
Bitcoin, Ethereum, DeFi protocols, and digital asset market dynamics
Stablecoin volume has quadrupled in under 3 years. Stablecoin volume has quadrupled in under three years. JPMorgan's assessment suggests that this sector is just beginning to expand.
$300B stablecoin market now eclipses OpenAI’s $157B tag and matches PayPal’s annual TPV, funneling risk-free yield to Tether and Circle like shadow money-market funds. I’ve seen banks hate lost float. Watch JPMorgan spearhead a regulated rival rail by 2027.
Market Pulse
Daily market data: indices, sectors, top movers, and volatility
Markets Up. The S&P 500 climbed by 0.7%, Nasdaq 100 rose by 1.8%, while the Dow Jones dipped by 0.3%. Technology stocks led the charge with a 2.7% gain, whereas Healthcare lagged at -1.5%. The VIX spiked to 39.1. Key movers included ARM at +14.7%, AMD at +13.5%, and SMCI at +8.8%. This reflects a dynamic sector rotation favoring Technology over Healthcare.
Goldman Sachs indicates that the VIX in a high regime correlates with increased hedging demand, suggesting that investors will likely pursue protective strategies in the coming weeks as market volatility remains elevated. Expect heightened hedging activity through the end of Q1 2024.